Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 58(2): 159-165, 2024 Feb 06.
Artículo en Zh | MEDLINE | ID: mdl-38387944

RESUMEN

With the development of information technology and the increasing demand for vaccination services among the people, it is a definite trend to enhance the quality of vaccination services through digitization. This article starts with a clear concept of digital services for vaccination, introduces the current development status in China and abroad, analyzes the advantages and disadvantages of existing models in leading regions, takes a glean from the summation, and proposes targeted solutions. This study suggests establishing a departmental coordination mechanism for data interconnection and sharing, formulating data standards and functional specifications, enhancing the functionalities of the immunization planning information system, strengthening data collection and analytical usage, and intensifying appointment management and science and health education to provide expert guidance for the construction of digital vaccination services across the country in the future.


Asunto(s)
Inmunización , Vacunación , Humanos , Educación en Salud , China
2.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(10): 1484-1486, 2022 Oct 06.
Artículo en Zh | MEDLINE | ID: mdl-36274618

RESUMEN

To analyze the usage and loss of the COVID-19 vaccine in ten districts of Suzhou city from December 18, 2020 to April 30, 2021.The results showed the loss rate was 0.222‰ in Suzhou city. The loss rate of pre-filled packaging COVID-19 vaccine was higher than that of vial packaging. The loss rate of 40 packaging was the lowest in vial packaging. The loss rate of all kinds of COVID-19 vaccine in stable inoculation unit was the lowest. It is recommended to distribute 40 vial packaging COVID-19 vaccine for centralized vaccination to reduce the loss of COVID-19 vaccine.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Humanos , COVID-19/prevención & control , Vacunación , Ciudades , Embalaje de Medicamentos
5.
Sci Sin ; 24(9): 1313-24, 1981 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7302560

RESUMEN

The theory of dissipative structure is applied to the study of atherosclerosis. An autocatalytic theoretical model is suggested. The behaviors of the model are in agreement with the facts of experimental atherosclerosis. We predict the high effectiveness of combinative therapy for atherosclerosis with drugs affecting protein metabolism and lipid metabolism. It was verified by animal experimentation. Further possible developments are briefly discussed. This work is the theoretical foundation of the Multi-Risk Factor Intervention trial (MRFIT) which is popularized clinically in its beginning all over the world.


Asunto(s)
Arteriosclerosis/etiología , Modelos Biológicos , Animales , Arterias/patología , Arteriosclerosis/tratamiento farmacológico , Humanos , Matemática , Conejos
6.
Virology ; 212(2): 367-82, 1995 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-7571406

RESUMEN

Characterization of the SRS murine retrovirus complex, derived from the TSZ system of murine leukemia developed in China, was carried out. The initial stock contained XC+, NB-tropic virus (and possibly other viruses), and induced several neoplastic diseases in neonatally inoculated NIH Swiss mice: erythroid leukemia, myeloid leukemia (acute myeloblastic leukemia), and lymphoblastic lymphoma (both B- and T-lymphoid). In addition, approximately 30% of inoculated animals developed central nervous system disease--hindlimb paralysis or semilateral paralysis. Rescue of virus from the spleen of an animal with combined erythroid/myeloid leukemia, followed by endpoint dilution gave two stocks: 19-6 (XC+, NB-tropic) and 19-7 (XC-, NB-tropic). Both stocks induced erythroid and myeloid leukemia, and 19-6 induced CNS symptoms as well. Southern blot analysis indicated that the predominant viruses from the 19-6 and the 19-7 cultures were related, but different in the env region. An infectious virus molecular clone of provirus from 19-6 cells was obtained. The resulting cloned virus [SRS 19-6 murine leukemia virus (MuLV)] induced four kinds of leukemia: erythroid, myeloid, B-lymphoma, and T-lymphoma; in many cases, more than one tumor type was identified in the same animal. Such a broad spectrum of leukemias induced by a cloned MuLV is unusual. Flaccid hindlimb paralysis induced by SRS 19-6 MuLV could be attributed to meningeal B-lymphoma. Immunofluorescent staining with a panel of env-specific monoclonal antibodies confirmed that the 19-6 and 19-7 viral stocks contained different viruses, which differed from previously characterized MuLVs. The viruses of the SRS complex may provide interesting reagents for investigations of MuLV-induced disease.


Asunto(s)
Virus de la Leucemia Murina/genética , Leucemia Experimental/virología , Infecciones por Retroviridae/virología , Infecciones Tumorales por Virus/virología , Animales , Animales Recién Nacidos , Secuencia de Bases , China , Clonación Molecular , ADN Viral/genética , Genes env/genética , Virus de la Leucemia Murina/patogenicidad , Leucemia Experimental/patología , Ratones , Datos de Secuencia Molecular , Parálisis/virología , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/virología , Provirus/genética , Mapeo Restrictivo , Infecciones por Retroviridae/patología , Análisis de Secuencia de ADN , Bazo/virología , Infecciones Tumorales por Virus/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA